Biomedicine Select  by unknown
Leading Edge
Biomedicine SelectThis issue’s Biomedicine Select highlights new insights into the role of mitochondria in disease. Several new
studies implicate abnormal mitochondria in the destruction of neurons of the substantia nigra, the cause of Par-
kinson’s disease (PD). Meanwhile, an elegant computational approach has enabled identification of candidate
genes for several mitochondrial diseases including the mitochondrial DNA (mtDNA) depletion syndrome.
Implicating a Powerhouse in Parkinson’s Disease
Death of dopaminergic neurons in the brain’s substantia nigra, a cardinal feature of
Parkinson’s disease (PD), causes the severe motor abnormalities characteristic of
this debilitating disorder. Dysfunctional mitochondria are thought to play some role
in the degeneration of dopaminergic neurons, but it has not been clear how they might
be involved. Mutations in several genes—including PTEN-induced kinase 1 (PINK1)
and parkin (PARK2)—have been found in rare familial forms of PD. PINK1 encodes
a serine/threonine kinase and has a mitochondrial targeting sequence, whereas par-
kin encodes an E3 ubiquitin ligase; both proteins are localized to mitochondria. Many
of the amino acid residues in PINK1 that are mutated in familial PD are conserved in
the Drosophila homolog of this protein.
In two new studies, Clark et al. (2006) and Park et al. (2006) generated loss-of-func-
tion mutations in the pink1 gene of Drosophila. They report that Pink1-deficient flies
show severe mitochondrial abnormalities that result in several marked defects includ-
ing sterility in males due to abnormal mitochondria in spermatids. Importantly, Park
et al. found that 30-day-old mutant flies exhibited a small decrease in a subset of brain
dopaminergic neurons and that the brains of these flies produced less dopamine. In
addition, the mitochondria in the dopaminergic neurons, and in other brain neurons of the pink1 mutants, were
greatly swollen (see Figure). Although Clark et al. did not observe death of dopaminergic neurons in the brains of their
Pink1-deficient flies, they did report that these flies were more sensitive than their wild-type counterparts to multiple
types of stress including oxidative stress, which has been implicated in PD pathogenesis. Both groups observed that
pink1 mutant flies had shorter life spans than wild-type flies.
Clark, Park, and their colleagues also observed a pronounced wing phenotype in the mutant flies, which were
unable to fly properly. They discovered similar flight muscle defects: disorganized muscle fibers, abnormal mito-
chondria, reduced ATP production, and muscle degeneration due to apoptosis. Park et al. also observed a reduction
in the amount of mtDNA and protein in these mutant flight muscles. As the antiapoptotic protein Bcl-2 is known to
protect mitochondrial integrity, Park et al. overexpressed Buffy (the fly homolog of Bcl-2) in pink1 mutant flies and
reported rescue of mitochondrial defects and amelioration of most of the mutant phenotypes.
The defects exhibited by pink1 mutant flies are reminiscent of those of parkin fly mutants, prompting both groups
to examine the relationship between these two genes. Overexpression of Parkin in Pink1-deficient flies ameliorated
the mutant phenotype (including mitochondrial swelling in brain dopaminergic neurons), whereas overexpression of
Pink1 in parkin fly mutants did not; double fly mutants did not show an increase in phenotype severity. The results of
this genetic approach suggest that parkin and pink1 appear to be in the same pathway with pink1 acting upstream
of parkin to contribute to mitochondrial function. Lack of Pink1 results in abnormal mitochondria that may prompt
the demise of cells with high energy requirements such as dopaminergic neurons, suggesting that mitochondrial
dysfunction may be involved in PD. The next step will be to take a biochemical approach to elucidating other com-
ponents of the pink1-parkin pathway and the importance of this pathway to mitochondrial integrity.
I.E. Clark et al. (2006). Nature. Published online May 3, 2006. 10.1038/nature04779.
J. Park et al. (2006). Nature. Published online May 3, 2006. 10.1038/nature04788.
Mutant mtDNA Pushes Dopaminergic Neurons over the Edge
A number of mitochondrial DNA (mtDNA) mutations including mtDNA deletions are associated with tissue degener-
ation and aging. In a pair of complementary studies, Bender et al. (2006) and Kraytsberg et al. (2006) set out to
examine a possible connection between mtDNA deletions and the degeneration of neurons in the substantia nigra,
the cause of PD. Using postmortem midbrain sections from PD patients and age-matched controls, Bender et al.
confirmed that PD neurons are deficient in cytochrome c oxidase, an enzyme of the mitochondrial respiratory chain
complex. Both groups used long-range PCR to identify deletions in individual dopaminergic neurons of the substan-
tia nigra followed by quantitative real-time PCR (Bender et al.) or quantitative single-molecule PCR (Kraytsberg et al.)
to measure mtDNA deletions. Bender et al. found a greater number of mtDNA deletions in the substantia nigra neu-
rons of postmortem brain tissue from PD patients compared to age-matched controls. Interestingly, there were more
mtDNA deletions in samples from older PD patients compared to younger PD patients, but there were lower levels of
mtDNA deletions in other PD brain neurons such as those of the hippocampus. Kraytsberg et al. examined mtDNA in
the substantia nigra of postmortem brains from individuals (33–102 years of age) who did not have PD. Importantly,
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neurons from older individuals who did not have PD showed an increase in
mtDNA deletions, indicating that such deletions accumulate in substantia ni-
gra neurons even in healthy people as they age. Both studies reveal that the
increase in mtDNA deletions in neurons of the substantia nigra correlates
with a loss in cytochrome c oxidase activity and impaired oxidative phos-
phorylation in these cells. Given that the neurons of the substantia nigra
are highly energetic cells, the stress imposed on them by diminished ATP
production through loss of cytochrome c oxidase activity could induce
them to undergo apoptosis. This may result in mild parkinsonian symptoms
often found in those who are over 80 years old, or, in the event of other
genetic or environmental factors, PD.
A. Bender et al. (2006). Nat. Genet. 38, 515–517. Published online April 9,
2006. 10.1038/ng1769.
Y. Kraytsberg et al. (2006). Nat. Genet. 38, 518–520. Published online April 9,
2006. 10.1038/ng1778.
Mitochondria Meet Their Maestro
There are a number of diseases associated with defects in mitochondrial respiration such as the mitochondrial
encephalomyopathies. Interestingly, most mitochondrial disorders are associated with mutations in nuclear genes
(encoding mitochondrial proteins) rather than in genes that belong to the mitochondrial genome. Only one-half of
nuclear-encoded proteins that are localized to the mitochondria have been identified, so Calvo et al. (2006) decided
to apply a computational strategy to identify more. These investigators designed a program called Maestro that in-
tegrates information from eight data sets to determine whether a particular protein has a mitochondrial function. The
authors applied Maestro to 33,860 human proteins and each protein was assigned a score based on the following
criteria: presence of a mitochondrial targeting sequence; presence of protein domains exclusive to mitochondrial
proteins; presence of evolutionarily conserved transcriptional regulatory elements found in mitochondrial genes; lo-
calization to the mitochondria; sequence similarity to yeast mitochondrial proteins; sequence similarity to Rickettsia
(the bacterium that is most closely related in evolutionary terms to mitochondria); transcriptional coexpression with
mitochondrial genes; identification in a previous proteomics study of mitochondria; and production when mitochon-
drial biogenesis is stimulated. Maestro accurately picked out 71% of known mitochondrial proteins and identified
490 proteins that were not previously known to be associated with mitochondria. Nineteen of these candidates
were confirmed using mass spectrometry of purified liver mitochondria, and through GFP-tagging and microscopy.
The authors then applied Maestro to identify candidate genes for mitochondrial diseases, given that only a few of the
genes that are mutated in these diseases have been identified. Other studies using traditional genetic techniques
(such as linkage analysis) have narrowed down genomic regions containing nuclear genes associated with several
mitochondrial diseases to a few large genomic segments. Combining Maestro with information from the literature,
Calvo et al. were able to identify mitochondrial candidate genes for eight mitochondrial disorders including hepatic
mtDNA depletion syndrome.
The mtDNA depletion syndromes are characterized by a large decrease in mtDNA in specific tissues, ultimately
leading to organ failure. Extending the findings of Calvo et al., Spinazzola and colleagues (2006) examined three fam-
ilies with the hepatocerebral form of mtDNA depletion syndrome. Both the clinical and biochemical features of this
disease pointed to a defect in a mitochondrial protein. The authors mapped the dis-
ease gene locus to a region on human chromosome 2 and then applied the Maestro
computational program to hone in on the disease gene candidates within that region.
This region includes the human ortholog of the mouse Mpv17 gene, which Maestro
predicted to encode a mitochondrial protein. This gene was found to be mutated in
all affected members of the three families. Corresponding mutations in the yeast
homolog of this gene resulted in a defect in aerobic respiration and instability of the
mtDNA. The authors demonstrate that the MPV17 protein is localized to the inner
mitochondrial membrane of cultured cell lines. Mice lacking Mpv17 have reduced
mtDNA in many tissues, and their liver cells exhibit reduced oxidative phosphorylation.
Although the exact function of this protein remains unknown, the Spinazzola et al.
study convincingly demonstrates that MPV17 contributes to the hepatocerebral
form of the mtDNA depletion syndrome and validates the use of Maestro to identify
genes involved in mitochondrial diseases.
S. Calvo et al. (2006). Nat. Genet. 38, 576–582. Published online April 2, 2006.
10.1038/ng1776.
A. Spinazzola et al. (2006). Nat. Genet. 38, 570–575. Published online April 2, 2006.
10.1038/ng1765.
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